Latest News about Health Canada Special Access Program
Recent news which mentions Health Canada Special Access Program
EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy
September 27, 2023
From Benzinga
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
September 08, 2023
Tickers
OPTHF
From Benzinga
PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
May 18, 2023
From Benzinga
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
March 28, 2023
From Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
February 06, 2023
From Benzinga
In Canada And In Jamaica You Can Produce Psychedelics — With Contrasting Legal Differences
January 11, 2023
From Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
December 21, 2022
From Benzinga
Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
September 26, 2022
Tickers
CLABF
From Benzinga
Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic
September 22, 2022
From Benzinga
Toronto Residents Get New Ketamine-Assisted Therapy Option Close To Home
September 19, 2022
Tickers
NUMIF
From Benzinga
What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
August 08, 2022
Tickers
OPTHF
From Benzinga
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
June 28, 2022
From Benzinga
Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
June 16, 2022
From Benzinga
Braxia Opens New Clinic in Ontario, Facilitating Further Access To Ketamine And Psilocybin Treatments
June 15, 2022
Tickers
BRAXF
From Benzinga